MGMT-Unmethylated Glioblastoma — Trials

MGMT-Unmethylated Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 7
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Northwestern University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06991101	Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma	recruiting	Phase 2	190	Baptist Health South FloridaOTHER	1	Jul 30, 2026	clinicaltrials
NCT05879250	WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma	recruiting	Phase 2	39	Northwestern UniversityOTHER	1	Jul 22, 2026	clinicaltrials